Clinical Trial Update: A Study of Amifostine for Prevention of Facial Numbness in Radiosurgery Treatment of Trigeminal Neuralgia [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating amifostine to prevent facial numbness after radiosurgery for trigeminal neuralgia was terminated. Results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Trigeminal Neuralgia

Drugs mentioned

• Amifostine (amifostine)

Snippet

Sponsor: Stanford University | Conditions: Trigeminal Neuralgia | Phase 3 | Status: TERMINATED | Results posted: 2017-04-04